Euglycaemic diabetic ketoacidosis in patients using sodium‐glucose co‐transporter 2 inhibitors

• DOI: 10.1111/imj.13442
• Publication Date: 2017-06-05T04:30:15Z
• Authors: Michelle Isaacs; Katherine T. Tonks; Jerry R. Greenfield
• Keywords: Diabetic ketoacidosis; Ketoacidosis

Sodium‐glucose co‐transporter 2 inhibitors ( SGLT2i ) are an increasingly prescribed class of medication for type diabetes mellitus. Euglycaemic diabetic ketoacidosis euDKA has been reported in association with use. Clinicians need to understand how recognise and treat this complication. We describe three cases patients treated .